CopyMark Law Group
4.9/5
Drawing for IMMUNOGLOBE

USPTO serial 86230340

IMMUNOGLOBE

Reviewed by CopyMark Law Group

Reg. 4631973Status 701Registered
Filing date
Status date
Registration date
Nov 4, 2014
Examiner
DIXON, JENNIFER HAZARD
Law office
TMO LAW OFFICE 110

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with IMMUNOGLOBE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cecelia M. Perry

Cecelia M. Perry McGlew and Tuttle, P.C.Scarborough StationScarborough, NY 10510United States

Goods and services

ClassDescriptionStatusFirst use
001Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biochemicals, namely, polypeptides for in vitro research use; Biological tissue, namely, sera, and other blood constituents, as well as human and animal tissue lysates for use in scientific and medical research; Chemical reagents for non-medical purposes, namely, for use in evaluating antibodies directed against an antigen of interest; Diagnostic preparations for scientific or research use; Diagnostic reagents for scientific or research use; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Protein in raw material form for scientific and medical research; Reagents for research purposesACTIVESep 3, 1997
042Biochemical research and development; Biotechnology research; Custom design and development of chemical reagents and biochemical assays; Development of new technology for others in the field of antibody technology, protein biochemistry, and biotechnology; Laboratory research in the field of antibody technology, protein biochemistry, and biotechnology; Product development in the field of antibody technology, protein biochemistry, and biotechnology; Product research and development; Providing scientific information in the field of antibody technology, protein biochemistry, and biotechnology; Research and development and consultation related thereto in the field of antibody technology, protein biochemistry, and biotechnology; Research and development of new products; Research and development of new products for others; Scientific and technological services, namely, scientific research, design, development and production of customized reagents and antibodies in the field of antibody technology, protein biochemistry, and biotechnology; Scientific laboratory services; Scientific research in the field of antibody technology, protein biochemistry, and biotechnologyACTIVESep 3, 1997

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 7, 2025CORVREVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD—
Dec 7, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 4, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Nov 1, 2024E89RTEAS SECTION 8 & 9 RECEIVED—
Nov 4, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 17, 2020NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Dec 17, 20208.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Dec 17, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 4, 2020ES8RTEAS SECTION 8 RECEIVED—
Nov 4, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 4, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 19, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 19, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 30, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 15, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 14, 2014ALIEASSIGNED TO LIE—
Jun 26, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 26, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Jun 26, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 26, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 26, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 25, 2014DOCKASSIGNED TO EXAMINER—
Apr 8, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Apr 5, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 27, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance